Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. Prognostic Significance of Resistance to Aspirin

NCT00262561 is registered in ClinicalTrials.gov with Aalborg University Hospital as lead sponsor.

NCT NCT00262561
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00262561 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Resistance to Aspirin and/or Clopidogrel Among Patients With PAD. Prognostic Significance of Resistance to Aspirin
Lead sponsor
Aalborg University Hospital
Phase
Phase 4
Overall status
Completed
Start date
January 31, 2006
Completion date
January 31, 2008
Enrollment
263 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intermittent claudication